SAVE THE DATE FOR WORLD ALLERGY WEEK 22-28 APRIL, 2018
World Allergy Week is a global campaign of the World Allergy Organisation (WAO) which aims to raise awareness of the impact of allergy in our communities. This years' theme is Atopic Dermatitis/Eczema: An Itch that Rashes.
Once again, AIFA will be supporting this global initiative through our 'wear a spot of red' campaign when we are asking our supporters to help raise awareness and funds to support research into allergy by wearing a spot of red or holding an event in their home, school or workplace.
Go to our website to register your interest in participating in this year's 'wear a spot of red' campaign. As we get closer to the date we will send you out a spot of red starter pack to help you kick off your event. Register your interest at www.allergyimmunology.org.au/support-aifa/worldallergyweek
We encourage everyone to organise an activity which will contribute to increased awareness about allergy. Why not organise a 'wear a spot of red' mufti day at work, decorate your workspace or classroom using 'a spot of red' or host a 'spot of red' morning tea or bake sale? Make sure you take some photos and post them to social media using #WorldAllergyWeek.
AIFA 2018 GRANT ROUND OPENS
Submissions for AIFA's current grant round opened January 15 and are due on March 15, 2018. AIFA supports innovative early stage projects, encourages collaborative research, prioritises early career researchers (working 3-5 years after completion of their PhD) and provides opportunities to leverage further funding.
Previously funded projects include Jack Jumper Ant allergy treatment, understanding FPIES and the AusPollen project. Last year's grant went to a project at the Garvan Institute investigating a new approach to overcome a childhood autoinflammatory disease, MKD. More details of these and other funded projects can be found on our projects page www.allergyimmunology.org.au/projects
TOP TIPS FOR HEADING BACK TO SCHOOL WITH ALLERGIES
Australian kids are heading back to school in the next week. For those whose kids have allergies, it's time to think of updating ASCIA action plans, making sure adrenaline (epinephrine) autoinjector devices are in date and informing the school and the teacher of a child's allergies.
It's important to remember that severe allergic reactions can also be caused by insect stings and ant bites, and allegic rhinitis (hay fever) affects 1 in 5 people in Australia and can have a negative impact on a child's performance at school. The experts in allergy, ASCIA, have a number of free downloadable information guides for schools, students and parents. You can access these resources and a range of other useful tools here.
This is also a good time to think of joining AIFA and the allergy community in raising awareness and fundraising for research. We are not just building awareness, we are taking action to find better treatments and cures.
Mylan has announced a shortage of EpiPen® 300mcg adrenaline (epinephrine) autoinjectors. Supply of EpiPen® Jr 150mcg adrenaline (epinephrine) autoinjectors is unaffected.
• Stock is expected to be available in pharmacies from mid-February 2018. • A process has been put in place by Mylan to ensure those at risk of anaphylaxis have access to the treatment they may need. Mylan has requested that patients requiring an EpiPen® 300mcg autoinjector contact their local pharmacy. Pharmacies can then contact Mylan by phoning 1800 274 276 or by emailing firstname.lastname@example.org to obtain instructions on how to access emergency supply. • Individuals will be able to access one in-date adrenaline autoinjector until the shortage resolves in mid-February 2018. • Patients and/or carers who require support should contact the national patient support organisations, Allergy & Anaphylaxis Australia via email email@example.com or by calling 1300 728 000 or Allergy New Zealand www.allergy.org.nz • In the case of anaphylaxis, patients and/or carers should follow instructions on their ASCIA Action Plan i.e. Give EpiPen® and call an ambulance by phoning 000 (AU) or 111 (NZ).
Use of expired adrenaline (epinephrine) autoinjectors
• It is important to note that a device expiring in February 2018 does not actually expire until the end of that month, not the start of that month. • Whilst the use of an expired adrenaline (epinephrine) autoinjector is not ideal, research suggests that recently expired devices retain potency. • Therefore, if no other adrenaline autoinjector is available, use of a recently expired device to treat anaphylaxis is advised, as stated on the ASCIA website: www.allergy.org.au/health-professionals/anaphylaxis-resources/adrenaline-autoinjector-storage-expiry-and-disposal
Allergy and Immunology Foundation of Australasia (AIFA) firstname.lastname@example.org Suite 238, 117 Old Pittwater Road, Brookvale NSW 2100 PO Box 450 Balgowlah NSW 2093 Australia Registered as a charity ABN: 45 615 521 452 All donations are tax deductible
AIFA aims to improve the health of people with allergy and other immune diseases by funding medical research